Itvisma 71894-0200
Generic: Onasemnogene Abeparvovec-Brve
Product NDC
71894-0200- Manufacturer
- Novartis Gene Therapies, Inc.
- Dosage Form
- Injection, Suspension
- Route
- Intrathecal
- Product Type
- Human Prescription Drug
- Marketing Start
- November 24, 2025
- Listing Expires
- December 31, 2026
- Application
- BLA125856
Need to source Itvisma? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Onasemnogene Abeparvovec | 40000000000000 [arb'U]/mL |
Packaging Options(1)
1 VIAL, SINGLE-DOSE in 1 CARTON (71894-200-02) / 3 mL in 1 VIAL, SINGLE-DOSE (71894-200-01)